Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer

P. Holý, V. Brynychová, K. Šeborová, V. Haničinec, R. Koževnikovová, M. Trnková, D. Vrána, J. Gatěk, K. Kopečková, M. Mrhalová, P. Souček

. 2023 ; 17 (10) : 2074-2089. [pub] 20230818

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc24001171

Oxysterols, oxidized derivatives of cholesterol, act in breast cancer (BC) as selective estrogen receptor modulators and affect cholesterol homeostasis, drug transport, nuclear and cell receptors, and other signaling proteins. Using data from three highly overlapping sets of patients (N = 162 in total) with early-stage estrogen-receptor-positive luminal BC-high-coverage targeted DNA sequencing (113 genes), mRNA sequencing, and full micro-RNA (miRNA) transcriptome microarrays-we describe complex oxysterol-related interaction (correlation) networks, with validation in public datasets (n = 538) and 11 databases. The ESR1-CH25H-INSIG1-ABCA9 axis was the most prominent, interconnected through miR-125b-5p, miR-99a-5p, miR-100-5p, miR-143-3p, miR-199b-5p, miR-376a-3p, and miR-376c-3p. Mutations in SC5D, CYP46A1, and its functionally linked gene set were associated with multiple differentially expressed oxysterol-related genes. STARD5 was upregulated in patients with positive lymph node status. High expression of hsa-miR-19b-3p was weakly associated with poor survival. This is the first study of oxysterol-related genes in BC that combines DNA, mRNA, and miRNA multiomics with detailed clinical data. Future studies should provide links between intratumoral oxysterol signaling depicted here, circulating oxysterol levels, and therapy outcomes, enabling eventual clinical exploitation of present findings.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001171
003      
CZ-PrNML
005      
20240213094415.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/1878-0261.13495 $2 doi
035    __
$a (PubMed)37491786
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Holý, Petr $u Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic $1 https://orcid.org/0000000269505563
245    10
$a Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer / $c P. Holý, V. Brynychová, K. Šeborová, V. Haničinec, R. Koževnikovová, M. Trnková, D. Vrána, J. Gatěk, K. Kopečková, M. Mrhalová, P. Souček
520    9_
$a Oxysterols, oxidized derivatives of cholesterol, act in breast cancer (BC) as selective estrogen receptor modulators and affect cholesterol homeostasis, drug transport, nuclear and cell receptors, and other signaling proteins. Using data from three highly overlapping sets of patients (N = 162 in total) with early-stage estrogen-receptor-positive luminal BC-high-coverage targeted DNA sequencing (113 genes), mRNA sequencing, and full micro-RNA (miRNA) transcriptome microarrays-we describe complex oxysterol-related interaction (correlation) networks, with validation in public datasets (n = 538) and 11 databases. The ESR1-CH25H-INSIG1-ABCA9 axis was the most prominent, interconnected through miR-125b-5p, miR-99a-5p, miR-100-5p, miR-143-3p, miR-199b-5p, miR-376a-3p, and miR-376c-3p. Mutations in SC5D, CYP46A1, and its functionally linked gene set were associated with multiple differentially expressed oxysterol-related genes. STARD5 was upregulated in patients with positive lymph node status. High expression of hsa-miR-19b-3p was weakly associated with poor survival. This is the first study of oxysterol-related genes in BC that combines DNA, mRNA, and miRNA multiomics with detailed clinical data. Future studies should provide links between intratumoral oxysterol signaling depicted here, circulating oxysterol levels, and therapy outcomes, enabling eventual clinical exploitation of present findings.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nádory prsu $x patologie $7 D001943
650    _2
$a messenger RNA $x genetika $7 D012333
650    12
$a oxysteroly $7 D000072376
650    12
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a transkriptom $x genetika $7 D059467
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Brynychová, Veronika $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic
700    1_
$a Šeborová, Karolína $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic
700    1_
$a Haničinec, Vojtěch $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Koževnikovová, Renata $u Department of Oncosurgery, MEDICON, Prague, Czech Republic
700    1_
$a Trnková, Markéta $u Aeskulab, k.s., Prague, Czech Republic
700    1_
$a Vrána, David $u Comprehensive Cancer Center Novy Jicin, Hospital Novy Jicin, Czech Republic
700    1_
$a Gatěk, Jiří $u Department of Surgery, EUC Hospital Zlin and Tomas Bata University in Zlin, Czech Republic
700    1_
$a Kopečková, Kateřina $u Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Mrhalová, Marcela $u Department of Pathology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Souček, Pavel $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic $1 https://orcid.org/0000000242946799 $7 xx0060511
773    0_
$w MED00167281 $t Molecular oncology $x 1878-0261 $g Roč. 17, č. 10 (2023), s. 2074-2089
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37491786 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094412 $b ABA008
999    __
$a ok $b bmc $g 2049648 $s 1210865
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 17 $c 10 $d 2074-2089 $e 20230818 $i 1878-0261 $m Molecular oncology $n Mol Oncol $x MED00167281
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Archiving options